Curtiss-Wright Operating Cash Flow decreased by 101.6% to -$5.66M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 85.4%, from -$38.77M to -$5.66M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 13.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $75.08M | $107.29M | $231.91M | -$124.32M | $31.04M | $95.66M | $292.39M | -$91.60M | $110.95M | $146.36M | $282.37M | -$45.63M | $111.34M | $177.27M | $301.30M | -$38.77M | $136.59M | $192.84M | $352.74M | -$5.66M |
| QoQ Change | — | +42.9% | +116.2% | -153.6% | +125.0% | +208.1% | +205.7% | -131.3% | +221.1% | +31.9% | +92.9% | -116.2% | +344.0% | +59.2% | +70.0% | -112.9% | +452.3% | +41.2% | +82.9% | -101.6% |
| YoY Change | — | — | — | — | -58.7% | -10.8% | +26.1% | +26.3% | +257.4% | +53.0% | -3.4% | +50.2% | +0.3% | +21.1% | +6.7% | +15.1% | +22.7% | +8.8% | +17.1% | +85.4% |